HAE Short Volume
Haemonetics Corporation (HAE) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $3.51B, listed on NYSE, employing roughly 3,657 people, carrying a beta of 0.54 to the broader market. Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. Led by Christopher A. Simon, public since 1991-05-10.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-30
- Short Volume
- 122.0K
- Total Volume
- 175.7K
- Short %
- 69.48%
- 30-Day Avg Short %
- 60.67%
Showing 30 days of FINRA short volume data for Haemonetics Corporation.
Learn how short volume is reported and how to read the data →
Frequently asked HAE short volume questions
- What is the daily HAE short volume?
- As of Jun 30, 2026, Haemonetics Corporation (HAE) short volume is 122.0K shares against 175.7K total reported volume, or 69.48% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is HAE short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does HAE short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.